Related Experiment Video
Updated: Dec 21, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
SnapShot: COVID-19
Blake Oberfeld1, Aditya Achanta1, Kendall Carpenter1
1Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Coronavirus disease 2019 (COVID-19) is a novel respiratory illness caused by SARS-CoV-2. Viral entry is mediated through viral spike protein and host ACE2 enzyme interaction. Most cases are mild; severe disease often involves cytokine storm and organ failure. Therapeutics including antivirals, immunomodulators, and vaccines are in development. To view this SnapShot, open or download the PDF.
Insights
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, can lead to severe illness. Research is ongoing for treatments like antivirals and vaccines to combat this respiratory illness.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- COVID-19 is a novel respiratory illness caused by the SARS-CoV-2 virus.
- Viral entry into host cells is facilitated by the interaction between the SARS-CoV-2 spike protein and the human ACE2 enzyme.
- While most COVID-19 cases present with mild symptoms, severe disease can manifest as cytokine storm and multi-organ failure.
Purpose of the Study:
- To provide an overview of COVID-19, its causative agent, and disease mechanisms.
- To highlight the current status of therapeutic development for COVID-19.
- To inform about the potential severity and complications associated with SARS-CoV-2 infection.
Main Methods:
- This is a summary of current knowledge on COVID-19.
- Information is compiled from existing research and clinical observations.
- No new experimental data was generated for this overview.
Main Results:
- SARS-CoV-2 utilizes the ACE2 enzyme for host cell entry, initiating infection.
- Severe COVID-19 is characterized by a dysregulated immune response (cytokine storm) leading to organ damage.
- Therapeutic strategies are under active investigation.
Conclusions:
- Understanding the SARS-CoV-2 lifecycle and pathogenesis is crucial for developing effective treatments.
- Antivirals, immunomodulators, and vaccines are key areas of therapeutic research.
- Continued research is essential to manage and mitigate the impact of COVID-19.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Principles of Disease Surveillance
Steps in Outbreak Investigation

